High interruption rates threaten patient safety

New research has found that pharmacists are interrupted at alarming rates when dispensing medicines. Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...

Could this medicine revolutionise schizophrenia treatment?

Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.

Oxybutynin for hot flashes when hormones can’t be used

Can oxybutynin be useful for some patients who are unsuited for hormonal pharmacotherapy? Some people might describe hot flashes as an unannounced and brief...

What pharmacists need to know about new prescribing pilots

On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.

Content unavailable

Sorry, this content is only available to users that the PSA have verified as healthcare professionals. To learn more, talk to a PSA membership...

Intranasal naloxone spray could reduce opioid-related deaths

Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...